Clinical trial
A Prospective, Multicenter, Pivotal Study With Randomized Controlled Prophylactic and Independent Therapeutic Cohorts to Evaluate the Safety and Efficacy of an Absorbable Vena Cava Filter for Pulmonary Embolism Prevention
NCT05127915 is registered in ClinicalTrials.gov with Adient Medical as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Multicenter, Pivotal Study With Randomized Controlled Prophylactic and Independent Therapeutic Cohorts to Evaluate the Safety and Efficacy of an Absorbable Vena Cava Filter for Pulmonary Embolism Prevention
- Lead sponsor
- Adient Medical
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- January 27, 2023
- Completion date
- December 31, 2026
- Enrollment
- 854 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.